Status:
COMPLETED
Colesevelam Versus Placebo in Cholestatic Pruritus
Lead Sponsor:
Foundation for Liver Research
Conditions:
Chronic Liver Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
38 patients with pruritus due to chronic cholestatic liver disease will be evaluated in an investigator initiated, multicenter, double-blind, placebo-controlled, 3-week study assessing the effects of ...
Eligibility Criteria
Inclusion
- patients with pruritus as a result of a cholestatic disorder
- age above 18 years
- informed consent
Exclusion
- use of cholestyramine
- pregnancy
- inability to understand or speak Dutch language
- malignancy/life expectancy \<6 months
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00756171
Start Date
September 1 2008
End Date
December 1 2009
Last Update
December 18 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam Medical Center
Amsterdam, Netherlands
2
Erasmus Medical Center
Rotterdam, Netherlands
3
University Medical Center Utrecht
Utrecht, Netherlands